Deborah Choquette

USPTO Granted Patents = 14 (Patent Applications = 4)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 8)

Average Co-Inventor Count = 10.6

ph-index = 8

Forward Citations = 306(Granted Patents)

Company Filing History:

Vertex Pharmaceuticals, Inc.

patents

Years Active: 2004-2017

where 'Filed Patents' based on already Granted Patents

14 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9556135 - Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use (2017-01-31),

2. 9115127 - Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase (2015-08-25),

3. 9066954 - Fused heterocyclic derivatives and methods of use (2015-06-30),

4. 8691838 - Heterocycles as protein kinase inhibitors (2014-04-08),

5. 8685983 - Method of treating cancer with substituted amide derivatives (2014-04-01),

6. 8524900 - Fused heterocyclic derivatives and methods of use (2013-09-03),

7. 8338455 - Compounds and methods of use (2012-12-25),

8. 8217177 - Fused heterocyclic derivatives and methods of use (2012-07-10),

9. 8212041 - Fused heterocyclic derivatives and methods of use (2012-07-03),

10. 8198448 - Fused heterocyclic derivatives and methods of use (2012-06-12),

11. 8178557 - Compounds and methods of use (2012-05-15),

12. 8088794 - Substituted amide derivatives and methods of use (2012-01-03),

13. 7435823 - Compounds and methods of use (2008-10-14),

14. 6825190 - Protein kinase inhibitors and uses thereof (2004-11-30),

Title: **Deborah Choquette: Innovator in Pharmaceutical Compounds**

Introduction

Deborah Choquette is an accomplished inventor based in Medford, MA, known for her groundbreaking work in the field of pharmaceuticals. With a remarkable portfolio of 14 patents, she has been at the forefront of developing innovative compounds aimed at addressing critical medical conditions, including Alzheimer's disease and various central nervous system disorders.

Latest Patents

Choquette's latest patents include the invention of amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds, which serve as beta-secretase antagonists. These compounds offer a novel approach for modulating beta-secretase enzyme (BACE) activity, providing potential treatments for disorders such as Alzheimer's disease and cognitive impairments. Her work also encompasses benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase, showcasing her versatility and competence in drug development.

Career Highlights

Throughout her career, Choquette has contributed her expertise to notable organizations such as Amgen Inc. and Vertex Pharmaceuticals, Inc. Her work has significantly impacted research and development in the pharmaceutical industry, generating innovative solutions for challenging health issues.

Collaborations

During her tenure in the industry, Choquette has collaborated with esteemed colleagues, including Jean-Christophe P Harmange and Steven F Bellon. These partnerships have further enhanced her research capabilities and led to the development of effective therapeutic strategies.

Conclusion

Deborah Choquette's contributions to the field of pharmaceuticals through her inventive spirit and extensive patent portfolio exemplify her dedication to improving healthcare. Her innovative compounds and collaborations highlight the importance of scientific research in addressing pressing medical needs.

This text is generated by artificial intelligence and may not be accurate.